rs1553638086

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong

The NM_001244008.2(KIF1A):​c.773C>T​(p.Thr258Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T258K) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

KIF1A
NM_001244008.2 missense

Scores

13
5
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:13

Conservation

PhyloP100: 9.69

Publications

4 publications found
Variant links:
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
KIF1A Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuropathy, hereditary sensory, type 2C
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 30
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • PEHO syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PM1
In a hotspot region, there are 12 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 11 uncertain in NM_001244008.2
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-240783764-G-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 1507070.Status of the report is criteria_provided_single_submitter, 1 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.921
PP5
Variant 2-240783764-G-A is Pathogenic according to our data. Variant chr2-240783764-G-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 464261.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1ANM_001244008.2 linkc.773C>T p.Thr258Met missense_variant Exon 8 of 49 ENST00000498729.9 NP_001230937.1 Q12756-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1AENST00000498729.9 linkc.773C>T p.Thr258Met missense_variant Exon 8 of 49 5 NM_001244008.2 ENSP00000438388.1 Q12756-3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
1431030
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
708762
African (AFR)
AF:
0.00
AC:
0
AN:
32820
American (AMR)
AF:
0.00
AC:
0
AN:
41062
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25542
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38146
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81480
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50196
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5724
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1096828
Other (OTH)
AF:
0.00
AC:
0
AN:
59232
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 30 Pathogenic:5
-
Genomics England Pilot Project, Genomics England
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 01, 2022
Solve-RD Consortium
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:provider interpretation

Variant confirmed as disease-causing by referring clinical team -

Apr 27, 2023
Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL)
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

- -

-
Paris Brain Institute, Inserm - ICM
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 15, 2020
SIB Swiss Institute of Bioinformatics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

This variant is interpreted as pathogenic for spastic paraplegia 30, autosomal dominant. The following ACMG Tag(s) were applied: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (PM2); Missense variant in a gene that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease (PP2); Multiple lines of computational evidence support a deleterious effect on the gene or gene product (PP3); De novo (paternity and maternity confirmed) (PS2); Prevalence in affected individuals statistically increased over controls (PS4 downgraded to supporting); Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (PP1). -

not provided Pathogenic:3
Dec 12, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate a damaging effect on selective binding to the GDP-bound lattice, motor activity, synaptic vesicle precursor delivery, and presynaptic strength in hippocampal neurons (PMID: 30612907, 28970574); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32045731, 28970574, 31488895, 32935419, 33880452, 37251230, 27535533, 37273706, 34983064, 34758253, 26125038, 21820098, 21376300, 30612907) -

Oct 23, 2020
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 13, 2023
Clinical Genetics Laboratory, Skane University Hospital Lund
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Pathogenic:1
Apr 09, 2018
Ambry Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Pathogenic:1
Nov 02, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neuropathy, hereditary sensory, type 2C Pathogenic:1
Oct 11, 2021
MGZ Medical Genetics Center
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability, autosomal dominant 9 Pathogenic:1
Sep 16, 2021
Clinical Genetics Laboratory, University Hospital Schleswig-Holstein
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Pathogenic:1
Oct 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 258 of the KIF1A protein (p.Thr258Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of HSP and hereditary spastic paraplegia (HSP) (PMID: 28970574; internal data). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 464261). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt KIF1A protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects KIF1A function (PMID: 28970574). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Pathogenic
0.31
D
BayesDel_noAF
Pathogenic
0.20
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.91
D;.;.;.;.;.;.;D;.;.;.;.;.
Eigen
Pathogenic
0.73
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.93
.;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Pathogenic
0.79
D
MetaRNN
Pathogenic
0.92
D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.77
D
MutationAssessor
Pathogenic
3.7
H;H;.;.;.;.;.;H;.;.;.;H;.
PhyloP100
9.7
PrimateAI
Pathogenic
0.87
D
PROVEAN
Pathogenic
-4.8
.;D;D;.;.;.;.;.;.;.;.;D;.
REVEL
Pathogenic
0.79
Sift
Pathogenic
0.0
.;D;D;.;.;.;.;.;.;.;.;D;.
Sift4G
Pathogenic
0.0
.;D;D;.;.;.;.;.;.;.;.;.;.
Polyphen
1.0
D;.;.;.;.;.;.;D;.;.;.;D;.
Vest4
0.80, 0.84
MutPred
0.65
Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);Loss of glycosylation at S257 (P = 0.0217);
MVP
0.89
MPC
2.1
ClinPred
1.0
D
GERP RS
3.4
Varity_R
0.76
gMVP
0.90
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1553638086; hg19: chr2-241723181; COSMIC: COSV57488905; API